Kellerhals Carrard advised Swiss chocolate manufacturer Maestrani Schweizer Schokoladen on its acquisition of Delafaille, a family business specialising in the production of Belgian truffles and pralines. The acquisition also includes the selling part’s Czech
Vischer advised Easternmed Real Estate Capital in its acquisition of a new prime commercial property in Geneva. The building in question is home to a hotel residence. The company Headquartered in Nicosia and listed with
Welcome to “signed sealed weekend”, our inside track on what’s happening in the Swiss legal market. Without further ado, let’s go through our news highlights of the week. In January 2025, Laurent Killias (pictured
Homburger advised the Julius Baer Group on its issuance of EUR 500 m notes. The issuance The operation took place indirectly through the ELM issuance vehicle, a repackaging issuance entity incorporated in the Netherlands. The notes &
Homburger advised Raiffeisen Schweiz Genossenschaft in connection with its role as sole lead manager on EFG Bank’s issuance of CHF 125 m 0.9625% bonds, maturing in 2029. EFG Bank completed the issuance on June 18th. The Homburger
Kellerhals Carrard advised the Bern-based sports medicine start-up Pershing Medical in its acquisition of the Ligamys™ product line—a technology for the natural healing of the anterior cruciate ligament (ACL)—from the international medical technology
Walder Wyss advised the Laveba cooperative group throughout renewing and simplifying its organisational structure. The context Headquartered in, the Laveba group is a cooperative trading and service company operating in the energy sector under the
Lenz & Staehelin successfully represented an estate composed by 19 heirs of former shareholders from a Libyan company as defendant in proceedings before the Swiss Federal Supreme Court. The context In connection with the matter, Libya
Niederer Kraft Frey advised gategroup Holding and its affiliates on the securing of a new EUR 675 million term loan, a USD 500 million term loan and a multicurrency revolving credit facility amounting CHF 300 million financing. In
Homburger advised ADC Therapeutics on its USD 100 m Private Placement of Common Shares and Pre-Funded Warrants. The context Headquartered in Switzerland and listed on the NYSE under the ticker ADCT, ADC Therapeutics is a commercial-stage
